Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.

Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during ...

Henry Schein, Inc. HSIC is scheduled to release fourth-quarter 2024 results on Feb. 25, before the opening bell. Find the ...

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...

Savant Capital LLC boosted its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 43.9% in the 4th quarter, ...

Chevy Chase Trust Holdings LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the ...

Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, ...

Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...

This was the stock's fourth consecutive day of losses.

Henry Schein, a distributor of healthcare products and services, has been named Formlabs' preferred North American reseller.